GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » AroCell AB (OSTO:AROC) » Definitions » 6-1 Month Momentum %

AroCell AB (OSTO:AROC) 6-1 Month Momentum % : -27.42% (As of May. 04, 2024)


View and export this data going back to 2011. Start your Free Trial

What is AroCell AB 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-04), AroCell AB's 6-1 Month Momentum % is -27.42%.

The industry rank for AroCell AB's 6-1 Month Momentum % or its related term are showing as below:

OSTO:AROC's 6-1 Month Momentum % is ranked worse than
75.64% of 234 companies
in the Medical Diagnostics & Research industry
Industry Median: -5.655 vs OSTO:AROC: -27.42

Competitive Comparison of AroCell AB's 6-1 Month Momentum %

For the Diagnostics & Research subindustry, AroCell AB's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AroCell AB's 6-1 Month Momentum % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, AroCell AB's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where AroCell AB's 6-1 Month Momentum % falls into.



AroCell AB  (OSTO:AROC) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AroCell AB  (OSTO:AROC) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


AroCell AB 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of AroCell AB's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


AroCell AB (OSTO:AROC) Business Description

Traded in Other Exchanges
N/A
Address
Uppsala Business Park, Virdings allé 32 B, Uppsala, SWE, 754 50
AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden.

AroCell AB (OSTO:AROC) Headlines

From GuruFocus

Archrock Announces Quarterly Cash Dividend

By GuruFocusNews GuruFocusNews 04-28-2022

Archrock Announces Quarterly Cash Dividend

By Marketwired 10-26-2023

Archrock Announces Timing for Fourth Quarter 2022 Results

By sperokesalga sperokesalga 02-13-2023

Archrock Increases Quarterly Cash Dividend

By GlobeNewswire GlobeNewswire 01-26-2023

Archrock Announces Quarterly Cash Dividend

By GuruFocusNews GuruFocusNews 01-27-2022

Archrock Increases Quarterly Cash Dividend

By Marketwired 07-27-2023

Archrock Announces Timing for Third Quarter 2021 Results

By Marketwired Marketwired 10-19-2021